Check the source
We look to literature, study registries, regulatory materials, and official sources, then identify the limits of what each can establish.
Independent resource / about
About Virellon
Virellon helps people understand the evolving evidence, risks, regulation, and unanswered questions around ibogaine for substance-use relapse prevention. It presents uncertainty plainly and prioritizes safety, context, and informed decision-making.
Operating posture
A clear resource for complex decisions.
01 / Independent
Information first, without presenting as a provider.
02 / Evidence-led
Sources and uncertainty are kept in view together.
03 / Safety-aware
Risk context is not treated as a footnote.
Why this exists
Context should be easier to find.
Virellon exists for people affected by substance use, families, advocates, and professionals who want careful context without a sales pitch. The main resource on relapse prevention is designed to make its scope clear while leaving room for uncertainty.
We organize material around the questions people often need to separate: what is known, what remains unsettled, where safety considerations enter, and how regulation or care settings can change the practical context. Our resource pathways describe how those areas are arranged for readers who need a more structured starting point.
When a claim depends on clinical research, the aim is to distinguish preliminary signals from settled conclusions. That approach aligns with the role of public trial registries such as ClinicalTrials.gov, which records studies and their status rather than turning an individual result into a recommendation.
Our editorial approach
Traceable inputs. Plain language.
Keep terms precise
We avoid blurring research, individual experience, marketing, and clinical advice into one category of claim.
Show the uncertainty
We state what is unresolved and avoid treating a promising question as a settled answer.
What we cover
A map for evaluating information.
Virellon brings related questions into view without asking readers to accept a single conclusion. The structure is meant to help people notice where evidence, safety, setting, and unanswered questions belong in the same conversation.
01 / RECORD
Literature and study records
02 / CONTEXT
Risk, regulation, and care setting
03 / REVIEW
Limits, gaps, and competing claims
04 / ORIENT
Questions for informed decisions
Who this is for
For people seeking careful context.
The resource is intended for people trying to make sense of claims, compare the quality of available information, or support conversations that call for more than a simple answer. It is not a substitute for individualized medical, legal, or treatment guidance.
Readers may arrive through different questions: relapse prevention context, questions about brain aging, cardiac-risk concerns, or fentanyl-related questions. Different entry points should not be mistaken for equivalent evidence or equivalent risk.
People also encounter differing accounts of support and supervision. Virellon encourages readers to distinguish those accounts from supervised ibogaine information and from official public-health guidance, including the SAMHSA National Helpline, which provides treatment-referral information in the United States.
Editorial principles
The standards we keep visible.
- Independence from clinic, provider, and treatment-center claims.
- Evidence before hype, with clear attention to source quality.
- Safety clarity rather than reassurance by omission.
- Plain language without flattening complexity.
- Respect for the limits of general information.
“The purpose is orientation: making it easier to see what a claim says, what supports it, and what it cannot answer.” Virellon editorial commitment
Independent by design
Information is not treatment.
Virellon is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice. This distinction matters when people encounter material about hockey-related experiences, football-related accounts, or Mexico ibogaine centers.
We do not treat personal stories, commercial information, or general summaries as replacements for individualized assessment. The same care applies to questions about ibogaine and alcohol, where a general resource cannot determine what is appropriate for any one person.
For definitions that need a common reference point, we may use established background sources such as evidence-based medicine, while keeping the focus on how claims are supported and where the available record stops.
Start with context
See how Virellon organizes the questions.
Explore the site’s resource pathways and use the material as a starting point for informed, safety-aware conversations.